MARKET

INZY

INZY

Inozyme Pharma, Inc.
NASDAQ
1.295
-0.195
-13.09%
Opening 11:13 05/06 EDT
OPEN
1.450
PREV CLOSE
1.490
HIGH
1.455
LOW
1.290
VOLUME
477.64K
TURNOVER
--
52 WEEK HIGH
6.24
52 WEEK LOW
0.7210
MARKET CAP
83.61M
P/E (TTM)
-0.7973
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INZY last week (0428-0502)?
Weekly Report · 1d ago
Weekly Report: what happened at INZY last week (0421-0425)?
Weekly Report · 04/28 09:04
Weekly Report: what happened at INZY last week (0414-0418)?
Weekly Report · 04/21 09:04
Weekly Report: what happened at INZY last week (0407-0411)?
Weekly Report · 04/14 09:03
Inozyme Pharma Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Dow Jones · 04/10 15:17
HC Wainwright & Co. Reiterates Buy on Inozyme Pharma, Maintains $16 Price Target
Benzinga · 04/10 15:07
Promising Potential of INZ-701 in Treating ENPP1 Deficiency Drives Buy Rating for Inozyme Pharma
TipRanks · 04/10 14:55
Inozyme announces JBMR Plus publication on ENPP1 deficiency
TipRanks · 04/10 12:41
More
About INZY
More
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. The Company is focused on developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue and skeleton. The Company is also focused on developing a novel therapy to treat the rare genetic diseases of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) and ATP-Binding Cassette in the C6 family (ABCC6) Deficiencies. The Company’s lead product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to cleave extracellular adenosine triphosphate (ATP) to generate plasma pyrophosphate (PPi) and adenosine monophosphate (AMP), which can be processed to phosphate and adenosine. Its INZ-701 is in clinical development for the treatment of ENPP1 Deficiency, ABCC6 Deficiency and calciphylaxis.
Recently
Symbol
Price
%Change

Webull offers Inozyme Pharma Inc stock information, including NASDAQ: INZY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INZY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INZY stock methods without spending real money on the virtual paper trading platform.